Background: Neurological detrusor overactivity (NDO) is commonly associated with various neurogenic diseases. Botulinum toxin A (BTX-A) has been proposed as alternatives to traditional treatments. Objective: To summarize the clinical experience of nursing care for the treatment of the Botulinum toxin A (BTX-A) injections due to neurological detrusor overactivity (NDO). Methods: We reviewed the data of 32 inpatients who received BTX-A injections between August 2014 to July 2016. Their mean age was 27.4 years old (range: 19 -38). They were all on clean intermittent catheterization. All patients presented detrusor overactivity resistant to oral anticholinergic treatment. Results: There were significant difference between outcomes at baseline and week12 for P detmax (60.08 cmH 2 O vs. 28.04 cmH 2 O, P < 0.001), V FIDC (165.55 ml vs. 276.07, P < 0.001), and urinary incontinence respectively. Prompt psychological counseling and nursing help reduce the patients' passive psychology, enhance their confidence with good postoperative recovery and symptoms improvement. Conclusions: Patients were satisfied with the treatment and nursing by targeted perioperative nursing.
Introduction
Neurological detrusor overactivity (NDO) is characterized by spontaneous or provoked involuntary detrusor contractions during storage phase in urodynamic investigation which caused by various neurogenic diseases such as Parkinson's disease, stroke and spinal cord injury [1] [2] . NDO can cause urinary inconti- (VUR); the most dangerous being damage of renal function [3] . Botulinum toxin A (BTX-A) is a neuromuscular blocking agent indicated by the beneficial treatment effect on NDO patients who have an inadequate response to or are intolerant to anticholinergic medication [4] . Therefore, encouraged by our satisfactory clinical effects, we summarized our perioperative nursing experience for BTX-A injection. 
Materials and Methods

Results
The records of 73 consecutive patients, who presented to the botulinum toxin consultation from August 2014 to July 2016, were analyzed. From these, 32 inpatients were treated with BTX-A for NDO.
The mean age was 27.4 years old (19 -38 years). They were all on clean intermittent catheterization. Table 2 shows that significant difference between outcomes at baseline and week 12 for P detmax (60.08 cmH 2 O vs. 28.04 cmH 2 O, P < 0.001), V FIDC (165.55 ml vs. 276.07, P < 0.001), and urinary incontinence respectively.
Discussion
The primary aim in the treatment of NDO is to ensure that the detrusor pressure remains within safe limits during both the filling phase and the voiding phase for protection of the upper urinary tract [6] . The present trial reports significant improvements in these parameters were evident with the 200-U dose of BTX-A injection [6] . Besides, the improvements in urodynamic outcomes also transfer to the increases in scores of the patient's quality of life.
Undoubtedly, our prompt nursing care also played an important role in this A limitation of this study is that the number of patients was relatively fewer.
Therefore, further studies are warranted.
Conclusions
Our results have demonstrated that Patients were satisfied with the treatment and nursing by targeted perioperative nursing.
